MARKET

CERC

CERC

Cerecor
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.360
+0.250
+8.04%
Closed 16:00 11/19 EST
OPEN
3.130
PREV CLOSE
3.110
HIGH
3.410
LOW
3.130
VOLUME
29.18K
TURNOVER
--
52 WEEK HIGH
7.65
52 WEEK LOW
2.710
MARKET CAP
148.20M
P/E (TTM)
-2.7707
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CERC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CERC News

  • Cerecor Q3 EPS $(0.35) Down From $(0.17) YoY, Sales $5.613M Up From $4.075M YoY
  • Benzinga.6d ago
  • Cerecor Reports Third Quarter 2019 Results
  • GlobeNewswire.6d ago
  • Cerecor Announces Clinical Updates on CERC-301 and CERC-802
  • GlobeNewswire.11/11 11:30
  • Cerecor to Sell its Pediatrics Portfolio to AYTU BioScience for $17M in Cash and Stock and $26M of Liabilities AYTU Will Assume
  • Benzinga.11/04 11:41

More

Industry

Biotechnology & Medical Research
+1.97%
Pharmaceuticals & Medical Research
+0.74%

Hot Stocks

Name
Price
%Change

About CERC

Cerecor, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company has a portfolio of clinical and preclinical compounds that it is developing for a range of indications, including CERC-301, which is an adjunctive treatment for major depressive disorder (MDD); CERC-501, which is for substance use disorders and adjunctive treatment of MDD, and CERC-406, which is for the treatment of cognitive impairment. The Company owns the rights to its COMTi platform. Catechol O methyltransferase (COMT) is an enzyme critical for the inactivation and metabolism of dopamine and its inhibition in the brain has applicability in treating subjects with neuropsychiatric conditions, including MDD, schizophrenia, Parkinson's disease and pathological gambling. Its COMTi platform comprises COMT inhibitors with selectivity for membrane bound COMT, which is the dominant form of COMT.
More

Webull offers Cerecor Inc (CERC) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.